Biotech · Private company
Azevan Pharmaceuticals
Track this companyFree. Adds Azevan Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- SRX246Phase 2 · Aggressive Behavior in Fragile X SyndomeClinicalTrials.gov · fetched Nov 12, 2026
- SRX246Phase 2 · Intermittent Explosive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- SRX246Phase 2 · Irritable MoodClinicalTrials.gov · fetched Nov 12, 2026
- SRX246Phase 2 · PTSDClinicalTrials.gov · fetched Nov 12, 2026
- SRX246Phase 1 · FearClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Inhibition of Aggressive Behavior in Participants With Fragile X SyndromePHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07328529 · fetched Nov 12, 2026
- Effects of SRX246 on an Experimental Model of Fear and Anxiety in HumansPHASE1 · UNKNOWN · started Feb 3, 2017ClinicalTrials.gov NCT02922166 · fetched Nov 12, 2026
- Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSDPHASE2 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT02733614 · fetched Nov 12, 2026
- Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's DiseasePHASE2 · COMPLETED · started May 10, 2016ClinicalTrials.gov NCT02507284 · fetched Nov 12, 2026
- Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive DisorderPHASE1_PHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02055638 · fetched Nov 12, 2026